Abstract
The development of a successful gene therapy has many stages, including preclinical testing in animal models and proof of principle clinical studies. A variety of diseases affect the lung, which are candidates for gene therapy; this review will mainly focus on the diseases that have attracted the most attention and have therefore yielded the most progress, namely lung cancer and the monogenic disorder cystic fibrosis. Knowledge gained from clinical studies could eventually be applied to more complex lung conditions such as acute respiratory distress syndrome and asthma. In addition, increased gene transfer efficiencies could be obtained by appropriate selection of the gene transfer vector and mode of delivery.
Article PDF
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Additional information
Received 8 August 2003; received after revision 10 September 2003; accepted 17 September 2003
Rights and permissions
About this article
Cite this article
Gill, D.R., Davies, L.A., Pringle, I.A. et al. The development of gene therapy for diseases of the lung. CMLS, Cell. Mol. Life Sci. 61, 355–368 (2004). https://doi.org/10.1007/s00018-003-3317-z
Issue Date:
DOI: https://doi.org/10.1007/s00018-003-3317-z